Deborah Mitchell, MD, is a clinician in the MGHfC Pediatric Endocrine Unit and a clinical investigator in the Endocrine Division of Mass General. She is the Associate Director of the pediatric endocrine training program at MGHfC and the Co-Director of the pediatric bone and mineral metabolism clinic.
- Centers & Specialties
- Clinical Interests
- Bone and mineral metabolism
- Type 1 diabetes
- Pediatric endocrinology
- Thyroid disorders
- Thyroid and adrenal disorders
- Medical Education
- MD, Harvard Medical School
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Pediatric Endocrinology
- Boston: Massachusetts General Hospital
- Existing Patients
- Patient Gateway
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
Deborah Mitchell, MD, is a pediatric endocrinologist with particular interests in calcium and bone metabolism. She completed pediatric residency at Massachusetts General Hospital for Children (MGHfC) in 2009, and a fellowship in pediatric endocrinology at MGHfC in 2012. She is the Associate Director of the pediatric endocrine training program at MGHfC and co-director of the pediatric Bone and Mineral Metabolism Clinic.
- Research Summary
Dr. Mitchell's research is concerned with factors which promote optimal bone growth and mineralization during childhood and adolescence, with a goal of preventing osteoporosis and fractures in adults. She is currently investigating bone accrual and microarchitecture in children with type 1 diabetes, a condition known to increase the risk of bone fragility. Her goal is to better understand why patients with diabetes are at increased risk of fracture in order to be able to design and test therapies to strengthen bones in this population.
In addition, Dr. Mitchell is interested in rare disorders of calcium and phosphate metabolism including hypoparathyroidism, pseudohypoparathyroidism, and X-linked hypophosphatemic rickets. In particular, her research has demonstrated extremely high rates of kidney disease among patients treated for hypoparathyroidism. Ongoing studies are investigating determinants of renal disease in this population as well as novel, targeted therapies.
Selected Research Articles:
- Mitchell DM, Caksa S, Yuan A, Bouxsein ML, Misra M, Burnett-Bowie SM. 2018. Trabecular bone morphology correlates with skeletal maturity and body composition in healthy adolescent girls. J Clin Endocrinol Metab.
- Mitchell D.M., Jüppner H, Burnett-Bowie SM. 2017. FGF23 is not associated with age-related changes in phosphate but enhances renal calcium reabsorption in girls. J Clin Endo Metab.
- Mitchell D.M., Leder B.Z., Cagliero E. Mendoza N., Henao M.P., Hayden D.L., Finkelstein J.S., and Burnett-Bowie S.M. 2015. Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial. Am Journal of Clin Nutr
- Mitchell D.M., Regan S., Cooley M.R., Lauter K.B., Vrla M.C., Becker C.B., Burnett-Bowie S.M., and Mannstadt M. 2012. Long-term follow-up of patients with hypoparathyroidism. J Clin Endo Metab
- Mitchell D.M. 2017 Growth in patients with type 1 diabetes. Curr Opin Endo Diab Obes.
- Mitchell D.M. and Jüppner H. 2010. Regulation of calcium homeostasis and bone metabolism in the fetus and neonate. Curr Opin Endo Diab Obes.
Childhood is a critical time for bone health. Approximately 90% of peak bone mass is acquired by age 18, with about 50% of this acquired during the pubertal growth spurt. As a pediatrician, my research goal is to better understand the factors which impact bone growth and mineralization during this important window in order to maximize long-term bone health.
55 Fruit Street
Boston, MA 02114-2696